Company History

1986 Foundation of Spiegelberg KG, with a head office in Hamburg, as a spin-out from the Free University of Berlin
1989 Start of production of ICP monitors and probes
1993 Change of corporation: Spiegelberg GmbH & Co. KG
2004 Development of the Silverline® technology for probes and catheters. First product: CE-marked Silverline® Ventricular Drainage Catheter
2008 CE-mark for Silverline® Shunt Catheters for permanent implantation
2009 CE-mark for Silverline® Lumbar Drainage Catheter and Silverline® Subdural Drainage Catheter
2011 All corporate shares are taken over by SHS Medizintechnik Holding GmbH and two private investors.
2011 Frank Sodha joins as Managing Director
2013 Spiegelberg opens a new modern production room to increase production output to exceed customer demands
2014 Spiegelberg launches new and improved ICP-Monitor HDM29.2
2015 Ingo Distel is appointed Managing Director Sales & Marketing
2016 Frank Sodha resigns from his role of Managing Director and Stefan Paschko joins as Managing Director Operations
2017 Ingo Distel resigns from his role of Managing Director and Stefan Paschko is appointed Managing Director

November, 2015
Easy tunneling with our new True Tunneling Intraventricular Probes
Read more…

Spiegelberg True Tunneling Intraventricular Probes


June, 2014
Hydrocephalus Shunt Systems from HpBio now distributed by Spiegelberg Read more…

Hydrocephalus Shunt Systems from HpBio


March, 2014
New and improved ICP-Monitor HDM29.2
Read more…

New and improved ICP-Monitor HDM29.2